Endometrial adenocarcinoma and adenomyosis are both common pathologic conditions that develop in the uterus.
Adenocarcinoma arising from adenomyosis is rare but has been described, with similar alterations in the endometrium. Furthermore, there have been a few reports of adenocarcinoma developing in adenomyotic areas without endometrial involvement (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) .
We report a case of endometrial adenocarcinoma arising in a focus of adenomyosis localized in the outer half of the myometrium, with no involvement of the surface of the endometrium.
Case report
OFBGB, a 62-year-old, nulliparous, white woman, presented with postmenopausal bleeding for 2 years with no other complaints.
Menarche at the age of 11 years. Menopause at the age of 53 years. She had been on antidiabetic and antihypertensive drugs for several years. She was an obese woman with a body mass index of 34.2. Dilatation and curettage (D & C) was performed, revealing endometrial hyperplasia with atypia. The serum level of CA-125 was within normal limits.
Magnetic resonance imaging of the pelvis showed four uterine nodules, with the biggest being 2 cm in diameter, hypodense at TI and T2, most probably corresponding to fibroids. In the myometrium there was a nodule with an intermediate sign at T1 and T2 that pushed inwards the adjacent endometrium. Inside this nodule there were two punctate images with an identical sign to that of the endometrium. This nodule may represent an area of adenomyosis (Fig. 1) . The nodule was well circumscribed and localized in the inner third of the myometrium. The endometrium had normal thickness throughout the cavity. The cervix was normal. Abnormal lymph nodes were not identified.
The patient underwent a total abdominal hysterectomy with bilateral adnexectomy.
Pathologic findings
Gross examination of the surgical specimen, showed a uterus (6.5 Â 4.0 Â 3.5 cm) covered by smooth, glistening mucosa. The endometrial cavity (4.5 cm in length) was a tiny slit with a tan-pink flat endometrium lining (0.2 cm in thickness on average).
The myometrium measured 2.0 cm in maximum thickness and contained several cystic hemorrhagic areas (adenomyosis) in the whole thickness, as well as several nodules that had a white-tan whorled appearance and no hemorrhage or necrosis, except for nodule (1.3 cm in its greatest dimension), subserosal, located on the lateral wall, near the fundus. It had a granular white appearance and was 0.7 cm away from the endometrial cavity.
Histologic findings
The normally situated endometrium was atrophic, without hyperplasia or malignant lesions (Fig. 2 ). There were several leiomyomas, as well as numerous adenomyotic foci in the whole thickness of the myometrium. The granular intramural nodule was a well-differentiated endometrioid adenocarcinoma, arising in adenomyosis (Fig. 3) , and transition from adenomyotic epithelium to adenocarcinoma was observed in several foci. There was no involvement of the uterine serosa, but there was minimal myometrial (outer half) invasion (Fig. 4) and lymphatic involvement.
Adjuvant therapy
Postoperative radiation was offered to the patient. She was well 6 months after surgery, is regularly followed up and, so far, has no signs or symptoms of tumor recurrence.
Discussion
Adenocarcinoma arising in adenomyosis of the uterus is uncommon. However, malignant transformation of the glandular epithelium in adenomyotic foci is possible, as these foci are downward extensions of the basal layer of the endometrium, which has considerable growth potential (11) . Thus, when persistent estrogenic stimulation is present, proliferative changes may occur in these foci, including hyperplasic changes that can develop into carcinoma.
There are a few documented cases of carcinoma arising in adenomyosis with or without endometrial involvement (1-10).
Rolly (1) published the first report in 1987. In 1980, a review of the literature carried out by Hernandez and Woodruff (5) revealed 16 cases of adenocarcinoma in adenomyosis. In eight of these cases the carcinoma was present only in adenomyotic foci; in the remaining eight cases there was malignant alteration in both surface and intramyometrial endometrium.
In 1986, Woodruff et al. (6) reported two more cases of adenocarcinoma arising in adenomyosis without surface endometrial changes. Both patients were postmenopausal women who underwent a total hysterectomy with bilateral adnexectomy because of persistent atypical cytologies, (7) reported a similar case of adenocarcinoma arising in adenomyosis without endometrial involvement, but there were already lymph node metastasis and involvement of the uterine serosa by the time the diagnosis was made. Thus, based on the International Federation of Gynecology and Obstetrics (FIGO) classification system, the case was classified as FIGO stage IIIc. They made an immunohistochemical analysis of the growth factors, including estrogen receptor (ER), progesterone receptor (PR), p53, bcl-2 protein and Ki-67 antigen, and found no expression of ER, PR or bcl-2 in the carcinoma cells. However, there was focal expression of p53 and prominent expression of Ki-67. These results suggest that some biological factors, including oncogenes and tumor suppressor genes, may play a role in the carcinogenesis of endometrial carcinoma arising from adenomyosis without surface endometrial changes.
In our case, the adenocarcinoma arose from an adenomyotic foci situated in the outer half of the myometrium, there was no malignant transformation on the surface of the endometrium, but the tumor invaded the adjacent myometrium. We found it difficult to classify this tumor, as the FIGO classification system does not foresee these cases. However, because there were myometrial invasion (on the outer half) and lymphatic involvement, we classified and treated this tumor as FIGO stage Ic. It is conceivable that in localized areas of adenomyosis, cellular changes occur, involving mutations of tumor suppressor genes and activation of oncogenes that may result in malignant transformation.
Additional cocarcinogenic factors, such as proliferative stimulation as a result of endogenous estrogens, may be responsible for further genomic instability that promotes development of cellular clones with invasive potential. In the present case, this hormonal stimulation might also have been operative, as it was diagnosed as an atypical hyperplasia, probably focal, which was completely removed by curettage.
Fortunately, adenocarcinomas arising in adenomyosis are rare events, because they generally represent pathologic findings of a surgical specimen.
Further efforts should be made to clarify the pathogenesis of these tumors, namely the genetic abnormalities encountered in neoplastic areas in comparison with the nontumor components of the adenomyotic focus.
Interstitial pregnancies account for 2-4% of all tubal pregnancies (1) and are especially feared because of their devastating outcome (2) . Even with advances in transvaginal ultrasound technology, and although interstitial gestations can be identified at an early asymptomatic stage (2) , it is still difficult to distinguish between an interstitial pregnancy and an angular pregnancy using two-dimensional (2D) transvaginal sonography (3). However, with the availability of 3D ultrasonography, diagnostic distinction between the various anatomic locations of tubal ectopic pregnancies is possible (4). This is of particular clinical importance as angular and interstitial pregnancies follow different clinical courses (5) . Here, we report a case in which 3D transvaginal sonography with multiplanar analysis was used to confirm the diagnosis of asymptomatic interstitial pregnancy at 6 weeks of gestation.
Case report
A 32-year-old woman, gravida 5 para 0, with a previous history of four recurrent first-trimester pregnancy losses, was referred to our antenatal diagnostic center at 6 weeks of amenorrhea for the evaluation and management of a leftsided tubal ectopic pregnancy. On presentation to us, the patient was asymptomatic. Her vital signs were stable and she had no pain or vaginal bleeding. Quantitative B-human chorionic gonadotropin (BhCG) concentration was 6671 IU/L. Two-dimensional transvaginal ultrasonography was performed, revealing a 15 mm Â 13 mm gestational sac containing a viable embryo with crown rump length of 5 mm close to the left uterotubal junction. A corpus luteum was noted in the right ovary measuring 12 mm Â 11 mm. Color flow Doppler ultrasound demonstrated a ring of fire sign, indicative of intense peritrophoblastic vascular activity surrounding the sac with resistance index of 0.64.
